Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Erythrocyte Indices MCV and/or MCH as First Round Screening Followed by Hb-analysis for β-thalassemia Carrier State

The Indonesian Biomedical Journal · Vol. 14 No. 3 (2022) · hlm. 282–288

DOI
10.18585/inabj.v14i3.1960
ISSN
2085-3297, 2355-9179
Terbit
2022-09-08
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Being located in the global thalassemia belt area, Indonesia is estimated harboring about 10% thalassemia carriers; however, screening program is still diversely scattered across the country. Numerous erythrocyte indices have been introduced to help identifying thalassemia carriers with contradictory results. Therefore, this study had compared the use of mean corpuscular volume (MCV) and/or mean corpuscular hemoglobin (MCH) values and the most erythrocyte indices used in Indonesia which were Mentzer Index (MI) and Shine & Lal Index (SLI), as a first attempt in a mass screening for β-thalassemia carrier.METHODS: This was a retrospective study, evaluating laboratory data from family members of thalassemia major subjects. The sensitivity and specificity of MI and SLI were calculated. HbA2 >3.5% was used as a golden standard for β-thalassemia carrier and DNA examination was conducted to confirm β-globin mutation.RESULTS: Out of 160, 28.8% of the subjects had low Hb concentration. Interestingly, 79.4% of the subjects had low MCV and/or MCH with or without low Hb concentration. In this study, specificity and sensitivity of MI were 82.2% and 83.8%, whereas of SLI were 96% and 40.5%, respectively. Low MCV and/or MCH had covered IVS1nt5 and Cd26 mutation at β-globin gene; whereas MI and SLI had missed some samples, leading to false negative of thalassemia carrier results, when using MI or SLI only.CONCLUSION: MCV<80 fl and/or MCH<27 pg is the best first round mass screening method for β-thalassemia carrier in a limited facility area. However, Hb electrophoresis should be gradually installed regionally in various places wherever possible, as well as DNA analysis to confirm the mutation for an optimal carrier diagnosis.KEYWORDS: HbA2, HbE, iron deficiency anemia, Mentzer Index, Shine and Lal Index

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 174 tautan kepenulisan bersama · 41 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • Dr. Hasan Sadikin General Hospital
  • Diponegoro University
  • Sumatera Institute of Technology
  • Universitas Jenderal Achmad Yani
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Herman SusantoDr. Hasan Sadikin General Hospital7
Ramdan PanigoroPadjadjaran University5
Ika Agus RiniSumatera Institute of Technology3
Nurul Setia RahayuPadjadjaran University3
Laniyati HamijoyoDr. Hasan Sadikin General Hospital2
Birgitta Maria DewayaniDr. Hasan Sadikin General Hospital2
Gatot Nyarumenteng Adhipurnawan WinarnoDr. Hasan Sadikin General Hospital2
Gita Widya PradiniPadjadjaran University2
Afini Tiara ResiPadjadjaran University1
Yuna Islamiati IslamiatiPadjadjaran University1
Shofia Dewi Fortuna FortunaPadjadjaran University1
Jessica Hamriani HamrianiPadjadjaran University1
Adhilizha Zumrotul Khasanah KhasanahPadjadjaran University1
Amira Husna Bestari BestariPadjadjaran University1
Muhammad Azka Arrazi ArraziPadjadjaran University1
Nevita Naira Dyahrani DyahraniPadjadjaran University1
Rania Ziamayra ZiamayraPadjadjaran University1
Muhammad Dzakwan Farisi FarisiPadjadjaran University1
Adika Ruhani Satiadi SatiadiPadjadjaran University1
Deasty Dini Imara ImaraPadjadjaran University1
Saskia Lenggogeni NasroenUniversitas Jenderal Achmad Yani1
Dikdik KurniaPadjadjaran University1
Muhammad Hasan BashariPadjadjaran University1
Eveline YuniartiPadjadjaran University1
Tenny PutriPadjadjaran University1
Nurul QomarillaPadjadjaran University1
Mieke Hermiawati SatariPadjadjaran University1
Fathul HudaPadjadjaran University1
Sultana MH FaradzDiponegoro University1
Tri Indah WinarniDiponegoro University1
Bremmy LaksonoDiponegoro University1
Syarief TaufikDiponegoro University1
Kevin Dominique TjandraprawiraPadjadjaran University1
Yudi Mulyana HidayatDr. Hasan Sadikin General Hospital1
Bethy Suryawathy HernowoDr. Hasan Sadikin General Hospital1
Maringan Diapari Lumban TobingDr. Hasan Sadikin General Hospital1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Erythrocyte Indices MCV and/or MCH as First Round Screening Followed by Hb-analysis for β-thalassemia Carrier State</dc:title><dc:creator>Edhyana Sahiratmadja</dc:creator><dc:creator>Ani Melani Maskoen</dc:creator><dc:creator>Lelani Reniarti</dc:creator><dc:creator>Delita Prihatni</dc:creator><dc:subject>mean corpuscular volume</dc:subject><dc:subject>mean corpuscular hemoglobin</dc:subject><dc:subject>red blood cell indices</dc:subject><dc:subject>Mentzer index</dc:subject><dc:subject>HbA2</dc:subject><dc:subject>HbE</dc:subject><dc:subject>iron deficiency anemia</dc:subject><dc:subject>beta-globin gene mutations</dc:subject><dc:subject>mass screening</dc:subject><dc:subject>screening sensitivity and specificity</dc:subject><dc:subject>Indonesia</dc:subject><dc:description xml:lang="en">BACKGROUND: Being located in the global thalassemia belt area, Indonesia is estimated harboring about 10% thalassemia carriers; however, screening program is still diversely scattered across the country. Numerous erythrocyte indices have been introduced to help identifying thalassemia carriers with contradictory results. Therefore, this study had compared the use of mean corpuscular volume (MCV) and/or mean corpuscular hemoglobin (MCH) values and the most erythrocyte indices used in Indonesia which were Mentzer Index (MI) and Shine &amp; Lal Index (SLI), as a first attempt in a mass screening for β-thalassemia carrier.METHODS: This was a retrospective study, evaluating laboratory data from family members of thalassemia major subjects. The sensitivity and specificity of MI and SLI were calculated. HbA2 &gt;3.5% was used as a golden standard for β-thalassemia carrier and DNA examination was conducted to confirm β-globin mutation.RESULTS: Out of 160, 28.8% of the subjects had low Hb concentration. Interestingly, 79.4% of the subjects had low MCV and/or MCH with or without low Hb concentration. In this study, specificity and sensitivity of MI were 82.2% and 83.8%, whereas of SLI were 96% and 40.5%, respectively. Low MCV and/or MCH had covered IVS1nt5 and Cd26 mutation at β-globin gene; whereas MI and SLI had missed some samples, leading to false negative of thalassemia carrier results, when using MI or SLI only.CONCLUSION: MCV&lt;80 fl and/or MCH&lt;27 pg is the best first round mass screening method for β-thalassemia carrier in a limited facility area. However, Hb electrophoresis should be gradually installed regionally in various places wherever possible, as well as DNA analysis to confirm the mutation for an optimal carrier diagnosis.KEYWORDS: HbA2, HbE, iron deficiency anemia, Mentzer Index, Shine and Lal Index</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2022-09-08</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v14i3.1960</dc:identifier><dc:identifier>10.18585/inabj.v14i3.1960</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 14 No 3 (2022); 282-288</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/1960/595</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>